ArticleScientific reports2016

Aflibercept and Ang1 supplementation improve neoadjuvant or adjuvant chemotherapy in a preclinical model of resectable breast cancer.

Florence T H Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.